Buy Stocks Easy | About Us
February 19, 2020
Buy Stocks Easy | Online Stocks

ZIOP


Buy ZIOPHARM Oncology Inc Stock (symbol: ZIOP) Easy Online

Company Name: ZIOPHARM Oncology Inc

Symbol: ZIOP

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2005

ZIOP Current Share Price

Today's ZIOP ( ZIOPHARM Oncology Inc ) opening price: $5.1700

Yesterday's ZIOP ( ZIOPHARM Oncology Inc ) closing price: $5.1300

ZIOPHARM Oncology Inc Stock ( symbol: ZIOP ) Price Chart since IPO (2005):

12 Months ZIOPHARM Oncology Inc Stock ( symbol: ZIOP ) Price Chart

Popular Questions about ZIOPHARM Oncology Inc Public Stock ( ZIOP )

A: ZIOPHARM Oncology Inc stock symbol (also called stock or share ticker) is ZIOP

A: ZIOPHARM Oncology Inc IPO (Initial Public Offering) took place on 2005

A: ZIOPHARM Oncology Inc's stock (ZIOP symbol) price at ther IPO (initial Public Offering) was $5.1700

Q: Is ZIOP stock worth buying at the moment?

A: If you were looking for a long-term investment portfolio and had bought the 'ZIOPHARM Oncology Inc stock (symbol: ZIOP) at the beginning of 2019, at the opening share price of $2.2400, with a minimum of $200, by now your shares would be worth $18056 and your profit would be $17856 - SHOW ONLY IF PROFIT.

Buy ZIOPHARM Oncology Inc Stock Easy Online

ZIOPHARM Oncology Inc Stock Ticker Price Chart since IPO:





ZIOPHARM Oncology Inc Stock Price Yesterday



 


ZIOPHARM Oncology Inc Stock Price – Last Week




 


ZIOPHARM Oncology Inc Stock Price – Last Month




 


ZIOPHARM Oncology Inc Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/09/1958239/0/en/Ziopharm-Oncology-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html
                            

                                
Ziopharm Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

                                
                                
BOSTON, Dec.  09, 2019  (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc....


                            

                        
                    

                


                            

                    


                        
                            https://www.benzinga.com/general/biotech/19/12/14931993/12-biotech-stocks-primed-for-a-short-squeeze
                            

                                
12 Biotech Stocks Primed For A Short Squeeze

                                
                                
Biotech investment is risk fraught. Most biotech stocks are at the ...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/23/1951656/0/en/Ziopharm-Oncology-Presents-Encouraging-Clinical-Data-for-Controlled-IL-12-for-the-Treatment-of-Recurrent-Glioblastoma-at-the-2019-Society-for-Neuro-Oncology-Annual-Meeting.html
                            

                                
Ziopharm Oncology Presents Encouraging Clinical Data for Controlled IL-12 for the Treatment of Recurrent Glioblastoma at the 2019 Society for Neuro-Oncology Annual Meeting

                                
                                
– Controlled IL-12 evaluated as monotherapy in an expanded number o...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4305222-ziopharm-oncology-inc-ziop-ceo-dr-laurence-cooper-q3-2019-results-earnings-call-transcript
                            

                                
ZIOPHARM Oncology, Inc. (ZIOP) CEO Dr.

                                
                                
ZIOPHARM Oncology, Inc. (ZIOP) CEO Dr.


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/28/1936170/0/en/Ziopharm-Oncology-and-MD-Anderson-Cancer-Center-Announce-New-R-D-Agreement-to-Expand-TCR-T-Program.html
                            

                                
Ziopharm Oncology and MD Anderson Cancer Center Announce New R&D Agreement to Expand TCR-T Program

                                
                                
–  Accelerates capability for TCR library expansion of T-cell recep...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/15/1929689/0/en/Ziopharm-Oncology-Names-Drug-Development-Leader-Dr-Chris-Bowden-to-Board-of-Directors.html
                            

                                
Ziopharm Oncology Names Drug Development Leader Dr. Chris Bowden to Board of Directors

                                
                                
– Industry veteran with 20+ years of global oncology drug developme...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4288511-ziopharm-oncology-attractive-entry-level-recent-pullback
                            

                                
Ziopharm Oncology: Attractive Entry Level After A Recent Pullback

                                
                                
ZIOPHARM declined 30% despite the absence of company-specific negat...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/08/28/1908050/0/en/Ziopharm-Oncology-to-Participate-in-the-Morgan-Stanley-17th-Annual-Global-Healthcare-Conference.html
                            

                                
Ziopharm Oncology to Participate in the Morgan Stanley  17th Annual Global Healthcare Conference

                                
                                
BOSTON, Aug.  28, 2019  (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc....


                            

                        
                    

                


                            

                    


                        
                            https://www.youtube.com/watch?v=AjGs2NeW1jI
                            

                                
Final trades: JPMorgan, Qualcomm, Waste Connections, Gap & Ziopharm Oncology

                                
                                
The "Halftime Report" traders give their top stocks to watch for th...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4283324-ziopharm-oncology-inc-ziop-ceo-laurence-cooper-q2-2019-results-earnings-call-transcript?source=feed_sector_transcripts
                            

                                
ZIOPHARM Oncology, Inc. (ZIOP) CEO Laurence Cooper on Q2 2019 Results - Earnings Call Transcript

                                
                                
ZIOPHARM Oncology, Inc. (ZIOP) CEO Laurence Cooper on Q2 2019 Resul...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.